Your browser doesn't support javascript.
loading
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.
Tolaney, Sara M; Boucher, Yves; Duda, Dan G; Martin, John D; Seano, Giorgio; Ancukiewicz, Marek; Barry, William T; Goel, Shom; Lahdenrata, Johanna; Isakoff, Steven J; Yeh, Eren D; Jain, Saloni R; Golshan, Mehra; Brock, Jane; Snuderl, Matija; Winer, Eric P; Krop, Ian E; Jain, Rakesh K.
Afiliación
  • Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114;
  • Boucher Y; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Duda DG; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Martin JD; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Seano G; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Ancukiewicz M; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Barry WT; Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114;
  • Goel S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Lahdenrata J; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Isakoff SJ; Department of Hematology/Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114;
  • Yeh ED; Department of Radiology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114;
  • Jain SR; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; Department of Chemical Engineering, Massachusetts Institute of Technology, Cambridge, MA 02139;
  • Golshan M; Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114;
  • Brock J; Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02114;
  • Snuderl M; Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114;
  • Krop IE; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA 02114; ikrop@partners.org jain@steele.mgh.harvard.edu.
  • Jain RK; Department of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114; ikrop@partners.org jain@steele.mgh.harvard.edu.
Proc Natl Acad Sci U S A ; 112(46): 14325-30, 2015 Nov 17.
Article en En | MEDLINE | ID: mdl-26578779
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Bevacizumab / Neovascularización Patológica Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Protocolos de Quimioterapia Combinada Antineoplásica / Biomarcadores de Tumor / Bevacizumab / Neovascularización Patológica Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2015 Tipo del documento: Article